https://www.selleckchem.com/pr....oducts/pf-4708671.ht
trical activity experienced an increase in ROSC when a physician was present but without improvement in survival to hospital discharge. Patient-derived tumor organoid culture has emerged as a preclinical model that has the potential to predict individual drug response. However, the predictive accuracy of patient-derived tumor organoid culture models for responses to chemotherapy regimens in stage IV colorectal cancer remains unknown. The purpose of this study was to evaluate the predictive accuracy of the patient-derived tumor organo
Like
Comment
Share
